Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest insulin pump Stories

2012-06-11 02:26:20

WEST CHESTER, Pa., June 11, 2012 /PRNewswire/ -- Results from the first feasibility study of an advanced first-generation artificial pancreas system were presented today at the 72nd Annual American Diabetes Association Meeting in Philadelphia. Findings from the study indicated that the Hypoglycemia-Hyperglycemia Minimizer (HHM) System was able to automatically predict a rise and fall in blood glucose and correspondingly increase and/or decrease insulin delivery safely. The HHM System...

2012-06-09 06:21:30

PHILADELPHIA, June 9, 2012 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the presentation of two posters at the 72nd Scientific Sessions of the American Diabetes Association (ADA) highlighting its research on improved treatment options for both the multiple daily injection therapy and continuous subcutaneous insulin infusion markets. (Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO) Presenters will be available to discuss the posters at the...

2012-06-07 02:28:45

Joint JDRF-Helmsley Charitable Trust Sensor Initiative Seeks to Accelerate Technology Innovation to Improve Glucose Control FRANKLIN LAKES, N.J. and NEW YORK, June 7, 2012 /PRNewswire-USNewswire/ -- JDRF and BD (Becton, Dickinson and Company) (NYSE:BDX) today announced an extension of their existing collaboration focused on Type 1 diabetes (T1D) to accelerate the development of BD's proprietary glucose-sensing technology which has shown promise in providing very accurate and...

2012-06-05 22:20:52

HORW, Switzerland, June 6, 2012 /PRNewswire/ -- CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced the initiation of a clinical study with the PaQ(® )Insulin Delivery Device. Professor Thomas Pieber, head of the Division of Endocrinology and Metabolism at the University Hospital Graz, Austria, is conducting the study. "This trial is an important step to demonstrate PaQ can be an effective option for the many people with type...

2012-06-01 02:24:25

-- Partnership Announced Between Leaders of Artificial Pancreas Research and Development to Develop Novel Redundant Sensor System to Help Improve Glucose Control for People with Diabetes -- NEW YORK, June 1, 2012 /PRNewswire-USNewswire/ -- JDRF in collaboration with the Helmsley Charitable Trust (HCT) announced today a partnership with Medtronic, Inc. (NYSE:MDT), a leader in artificial pancreas research and development. The JDRF-HCT Sensor Initiative aims to advance continuous glucose...

2012-05-30 02:24:08

PALO ALTO, Calif. and INDIANAPOLIS, May 30, 2012 /PRNewswire/ -- Glooko, Inc., makers of an innovative diabetes logbook solution, and Roche Diabetes Care, makers of ACCU-CHEK blood glucose monitoring systems, insulin pumps and information management solutions, today announced their co-promotion of the Glooko Logbook solution in the U.S. With the introduction of the Glooko IR Adapter, ACCU-CHEK customers who prefer to manage their diabetes on their iPhone or iPod touch can now use the Glooko...

2012-05-22 02:28:04

PRINCETON, N.J., May 22, 2012 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, announced today that the U.S. Food and Drug Administration (FDA) has approved Levemir(®) (insulin detemir [rDNA origin] injection) for use in children ages two to five years with type 1 diabetes. With the expansion of its pediatric indication, Levemir(®) is now available for type 1 diabetes patients from age two through adulthood and adult patients with type 2 diabetes. To view the multimedia...

2012-05-09 14:24:37

'Diabetes Insulin Guidance System' automatically updates weekly insulin dosage for better glycemic control, fewer hypoglycemic events Newly published results from a clinical study of the Diabetes Insulin Guidance System (DIGS), under development by Hygieia, Inc., demonstrate DIGS' potential to improve blood glucose control for insulin-using patients with type 2 or type 1 diabetes. DIGS automatically adjusted insulin dosage based on each individual's reported blood glucose results. Over the...

2012-04-24 02:29:37

--Novel Transmitter Will Simplify Artificial Pancreas Research by Eliminating a Separate CGM component-- NEW YORK, April 24, 2012 /PRNewswire-USNewswire/ -- JDRF, the leading global organization focused on type 1 diabetes (T1D) research, announced today that it has partnered with Dexcom, Inc. (Nasdaq: DXCM), a San Diego, CA-based medical device company focused on developing and marketing continuous glucose monitoring (CGM) systems. The goal of the partnership is to accelerate the...

2012-01-03 07:10:00

CHICAGO, Jan. 3, 2012 /PRNewswire/ -- "Beating Diabetes" is an encyclopedia of knowledge covering both type 1 and type 2 diabetes, from a physician who has had diabetes for more than 65 years. This unique eBook includes more than 1,000 questions from both patients and medical professionals. Learn from the physician who was the first to discover how to use a blood glucose monitor to manage diabetes and get over 1000 answers to questions your doctor may not know. "Beating Diabetes" will help...